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The processes leading to donor identification, consent,
organ procurement, and allocation continue to domi-
nate debates and efforts in the field of transplantation.
A considerable shortage of donors remains while the
number of patients needing organ transplantation in-
creases.
This article reviews the main trends in organ dona-
tion practices and procurement patterns from both de-
ceased and living sources in the USA. Although there
have been increases in living donation in recent years,
2002 witnessed a much more modest growth of 1%.
Absolute declines in living liver and lung donation
were also noted in 2002.
In 2002, the number of deceased donors increased by
only 1.6% (101 donors). Increased donation from de-
ceased donors provides more organs for transplanta-
tion than a comparable increase in living donation, be-
cause on average 3.6 organs are recovered from each
deceased donor. The total number of organs recovered
from deceased donors increased by 2.1% (462 organs).
Poor organ quality continued to be the major reason
Notes on Sources: The articles in this report are based on the
reference tables in the 2003 OPTN/SRTR Annual Report, which
are not included in this publication. Many relevant data appear
in figures and tables included here; other tables from the Annual
Report that serve as the basis for this article include the following:
Tables 1.1, 1.2, 2.1–2.4, 2.8, 2.9, and 3.1–3.18. All of these tables
are also available online at http://www.ustransplant.org.
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given for nonrecovery of consented organs from de-
ceased donors.
The kidney is the organ most likely to be discarded
after recovery. Over the past decade the discard rate
of recovered kidneys has increased from 6% to 11%.
Many of these are expanded criteria donor kidneys.
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Introduction
Organ donation is critical and central to successful re-
placement of end-stage organ failure with viable allogeneic
grafts. The processes leading to donor identification, solic-
itation and execution of consent, and organ procurement
and allocation continue to dominate debates and efforts
in the field of transplantation for four major reasons. First,
there remains a huge shortage of donors, while the num-
ber of patients needing organ transplantation continues to
increase unabatedly. Second, disparity exists between po-
tential supply and realization of donors. Third, allocation
policies remain contentious. Finally, American society is
far from consensus as to the right mix of motivations to
appropriately encourage more organ donation. This sec-
tion reviews the main trends in organ donation practices
and procurement patterns from both deceased and living
sources in the USA.
Unless otherwise noted, the statistics in this article come
from reference tables in the 2003 OPTN/SRTR Annual
Report. Two companion articles in this report, ‘Trans-
plant data: sources, collection, and caveats’ and ‘Ana-
lytical approaches for transplant research’, explain the
methods of data collection, organization, and analysis that
serve as the basis for this article (1,2). Additional detail
on the methods of analysis may be found in the ref-
erence tables themselves or in the Technical Notes of
the OPTN/SRTR Annual Report, both available online at
http://www.ustransplant.org.
Overview of the US Organ Procurement
System for Cadaveric Organs
Organ donation is a dynamic process that, in one sense,
may be considered complex and difficult because of the
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many institutions and people involved in every case. In an-
other sense, it may be considered the simple caring and
altruistic act of giving of one’s self as either a deceased
or living donor in order to help those in critical need. At
the very center of our nation’s highly successful provision
of transplant patient care is the organ procurement organi-
zation (OPO). Currently, there are 59 OPOs providing ser-
vices to the many institutional and individual constituents
within their specifically delineated donation service areas
(DSAs). Of these 59 OPOs, 50 are classified as indepen-
dent, freestanding organizations. The remaining nine are
classified as hospital-based organizations. OPOs operate
under contract with the Federal government, are desig-
nated by the Secretary of Health and Human Services,
are granted Medicare provider status for reimbursement,
file annual cost reports, participate in the nation’s Organ
Procurement and Transplant Network (OPTN), and are re-
quired to adhere to a number of structural, procedural, and
evolving performance standards and regulations articu-
lated in the Federal Register (Performance Standards
§486.310).
OPOs spend a considerable amount of time, energy, and
money establishing a positive donation environment in the
donor hospitals within their DSAs. Specifically, OPO staff
members educate hospital medical, nursing, and adminis-
trative personnel regarding potential donor identification,
the donor and family consent process, and donor mainte-
nance care prior to actual organ recovery. They work to de-
velop strong, trusting, and collaborative relationships with
the hospital’s trauma, critical care, neurosurgical, and neu-
rological specialists, because these individuals play a crit-
ical role in the success of the overall donation process.
Additionally, OPOs also strive to establish collegial, sup-
portive relationships with the medical examiner or coroner
within whose jurisdiction they are located. These relation-
ships are critical in the effort to maximize donation while
meeting the needs and requirements of these important
officials.
Historically, OPOs have focused a considerable amount of
energy and work on developing a smoothly running donor
identification and referral system at the local hospital level.
It was felt that by casting a wider net, OPO staff would have
an increased opportunity to meet with a greater number of
potential donor families and thereby be able to expand the
number and rate of actual donations. Fortunately, this pro-
cess of identifying all suitable potential donors was greatly
aided by Federal and state legislative efforts focused on
routine referral hospital strategies. OPOs continue to re-
fine the referral process at all of their donor hospitals with
an enhanced focus on those hospitals having the greatest
donor potential.
Consent to Organ Donation
With the donor identification and referral systems now
largely in place, the critical area of donor consent has come
to the forefront. In general, OPOs have tried to shift the bur-
den of requesting from hospital staff to OPO staff. OPOs
have focused on expanded training for those who obtain
consent and, in some cases, use only staff members who
have historically demonstrated their abilities at obtaining
consent.
It is important to note that ongoing public and professional
educational efforts continue to grow at a steady pace. The
current Federal administration and its supporting agencies
and divisions have been particularly focused on this im-
portant issue. A number of new initiatives are well under
way, and additional ones are under consideration. One of
the most exciting initiatives seeks to bring together the
leadership of key participants in the donation process (i.e.
hospital administration, medical examiners, OPOs, accred-
iting bodies, medical and surgical practitioners, critically re-
lated associations, and others) and develop collaborations
focused on real process improvements. The work of the
Association of Organ Procurement Organizations (AOPO),
the United Network for Organ Sharing (UNOS), the Coali-
tion on Donation, and the Southeastern Organ Procure-
ment Foundation (SEOPF), among others, in public out-
reach and donation-related education is also noteworthy.
In many states, living individuals may indicate their intent
to donate in the event of their death. Adding one’s name
to a registry during life may leave less ambiguity about a
decedent’s organ donation preferences. There continues
to be ongoing discussion concerning the role of donor reg-
istries in the consent process, as well as consideration of
ways to link such registries to improve their usefulness.
New legislative acts, referred to as ‘first-person consent
laws’, have been promulgated to make it possible for dona-
tion to take place using the donor’s valid donor card, entry
onto a donor registry, or driver’s license indication without
seeking the consent of the legal next-of-kin. This reaffirma-
tion of the donor’s intent represents a paradigm shift from
the current practice of relying upon donor next-of-kin for
consent.
For the past three decades, consent for recovery of or-
gans from deceased donors has been obtained primarily
from the donor family or legal surrogate. This occurred in
spite of the Uniform Anatomical Gift Act of 1968 (UAGA),
which established the precedence of donor authorization,
that is, of the donor’s wishes being legally binding. OPO
personnel, however, have been reluctant to seek donor
authorization for several reasons: the numbers with autho-
rization were small, locating and validating authorization
was difficult, and it was feared that upsetting the family by
pursuing recovery against their wishes might result in ad-
verse publicity or legal action. Supporting the donor family
through the consent process therefore became a primary
goal for many. It was noted, however, that the donor family
consent rate approached 95–100% when the donor’s wish
to donate was known by the family before death (3). More
recently, several OPOs have established policies to seek
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and honor the donor’s authorization while supporting the
donor family through the process of accepting the decision
of their loved one. Policies have also been established re-
garding ways to proceed with the recovery of organs when
the family disagrees with the authorization (B. Brosnick,
personal communication.).
These efforts have resulted in several states passing leg-
islation that reaffirms the UAGA laws, establishing more
efficient and proactive state registries with 24-h data ac-
cess and providing the legal security desired by the OPOs
to honor the donor’s wishes. This precedence of donor
authorization and the pursuit of donor rights legislation in
all 50 states were strongly endorsed by the participants
of a recent Consensus Conference on the Consent Pro-
cess conducted by the UNOS and subsequently by other
organizations including the Advisory Committee on Trans-
plantation (ACOT) to the Secretary of the Department of
Health and Human Services, AOPO, the Council of the
American Society of Transplant Surgeons (ASTS), and the
OPTN/UNOS Board of Directors (3). The challenge remains
how best to motivate the public to embrace this respon-
sibility of donation. The goals must be to expand the pool
of potential donors from a steady, but insufficient consent
rate of 50% to a positive environment in which individu-
als routinely authorize donation of their own organs and
provide donated organs in all medically suitable situations.
In 2002, the number of deceased donors increased by only
1.6% (101 donors). As indicated in this report last year, a
modest increase in donation from deceased donors will
provide considerably more organs for transplantation than
a substantially greater increase in living donors, because
the average number of organs recovered from deceased
donors is 3.6 (4).
The total number of organs recovered from deceased
donors has increased by 2.1% (462 organs) since 2001.
This includes increases of 195 kidneys (2%), 56 pancreata
(3%), 184 livers (4%), and 84 lungs (5%). The number of
hearts decreased by 54 (2%), continuing the steady decline
since a peak of 2525 in 1994 (Figure 1).
Nonrecovery of consented organs
Consent was obtained for 41 273 organs in 2002, but only
22 460 were recovered. The usefulness of these figures
is limited, however, because consent is usually obtained
by OPO coordinators for the recovery of all organs. The
consent process often occurs before the evaluation of in-
dividual organs is complete and offers are made to potential
recipients, therefore an indeterminate number of cases re-
sult in consent for donation of organs that will ultimately be
deemed not suitable for transplantation. Thus, a large pro-
portion of pancreata (61%), intestines (97%), hearts (50%),
and lungs (83%) from donors whose family gave consent
were not recovered compared with smaller numbers of
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Figure 2: Nonrecovery of consented organs, 2002.
Poor organ quality—a combination of poor organ func-
tion/infection and the organ unsatisfactory category (or-
gan damage or anatomic abnormalities)—continued to be
the major reason coded for nonrecovery of consented or-
gans. This reason was recorded for 61% of nonrecovered
kidneys, 48% of nonrecovered pancreata, 60% of nonre-
covered livers, 29% of nonrecovered intestines, 64% of
nonrecovered hearts, and 76% of nonrecovered lungs. A
greater percentage of intestines, however, were not recov-
ered due to the lack of an available recipient (35%) than for
organ quality. Although poor organ quality appears to be an
increasing cause of nonrecovery over the past 10 years,
this may be a reflection of more specific data entry, given
that the category ‘other’ has decreased to a similar degree.
The decision to abandon the recovery of consented or-
gans, as determined by OPO and transplant personnel, can
be subjective and variable. Additional effort needs to be
directed toward improving the ability of all organizations
to accurately assess the suitability of individual organs for
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transplantation and to develop national standards for this
decision-making process.
Consent for organ donation by type, organ, and year
As discussed above, successful identification and appro-
priate medical management of an eligible deceased donor
may not result in organ donation because the next-of-kin
or the individual acting as guardian may not grant con-
sent. In a recent study conducted by Sheehy et al. under
the auspices of the AOPO, medical record reviews in 36
OPOs (covering approximately one-half of the entire US
population) showed that an average of 54% of families ap-
proached gave consent for deceased organ donation (5).
In this study, the mean consent rate (proportion of fami-
lies asked who gave consent) ranged from 42–69%. Apart
from the geographic disparity in consent rates, marked
variation exists in consent rates by ethnicity, with minori-
ties exhibiting consent rates one-half that of nonHispanic
whites (6). There are multiple reasons why consent rates
vary. These include demographic differences across DSAs,
religious perceptions, poor communication between griev-
ing families and health care providers, perceived inequities
in the allocation system, and lack of knowledge of the wish
of the deceased (6). In addition, variability in the timing of
referrals from hospitals may have an impact on the oppor-
tunity for OPO requestors to meet with families to discuss
donation, and the level of interpersonal skill and sensitiv-
ity of requestors may not be uniform across all OPOs (7).
Ethnicity appears to be a strong predictor of willingness
to consent to donation (5). African-Americans consistently
have lower consent rates in multicenter studies, although
higher consent rates have been cited in single-center stud-
ies (8). It is unknown whether presumed consent (opt-out)
provisions would significantly affect consent rates in the
USA (8–10).
Organs from Deceased Donors
Donation after cardiac death
The recovery of organs from donors after cardiac death
(DCD)—the norm in the early years of transplantation—
was all but abandoned in the 1970s and 1980s with the
acceptance of brain death criteria. When death is deter-
mined by the irreversible cessation of circulatory and res-
piratory function, the donor has had an obligate period of
hypotension followed by cardiac arrest prior to organ re-
covery. Detrimental effects on organ function from the
requisite warm ischemia time and associated higher rates
of delayed graft function prompted most centers to rely
solely on brain-dead, heartbeating donors. As the gap be-
tween supply and demand for solid organs continues to
widen, however, more centers are reassessing the use of
organs from DCD donors. Two important papers were re-
cently published examining long-term function of kidneys
from DCD donors (11,12). Webb et al. in a single-center
study from Zurich, found no difference in death-censored
graft function at 5 and 10 years in kidneys from DCD donors
compared with brain-dead donors, in spite of a much higher
incidence of delayed graft function in the former (11). At 10
years, the death-censored rate of graft survival was 78.7%
for kidneys from DCD donors and 76.7% for kidneys from
brain-dead donors. Forty-six per cent of their donors were
uncontrolled, following unsuccessful cardiac resuscitation
(Maastricht category II). Rudich et al. in an analysis of adult
deceased donor transplants registered in the United States
Renal Data System (USRDS) between January 1993 and
June 2000, found the 6-year death-censored graft survival
comparable between DCD donors (73.2%) and brain-dead
donors (72.5%), despite nearly twice the incidence of de-
layed graft function in the DCD donors (12). These studies
provide convincing evidence that kidneys recovered from
DCD donors, after the attending physicians and family de-
termine it appropriate to withdraw supportive therapy, pro-
vide very acceptable kidneys for transplantation.
Nonetheless, the use of DCD donor kidneys remains low.
In 2002, organs were recovered from 191 DCD donors,
accounting for 3% of total deceased donors and a 13%
increase from 2001. These donors produced 185 kidneys,
22 pancreata, and 103 livers.
The effort required by OPOs to initiate recovery programs
for DCD donors is substantial, requiring considerable in-
vestment in time and resources, constructing protocols
to be approved by hospital ethics and patient care com-
mittees, and training intensive care unit, emergency de-
partment, and operating room personnel. The potential
for a 20–25% increase in the overall number of deceased
donors, however, would be well worth the effort (13).
Expanded criteria donors
The allocation system for the expedited placement of de-
fined ECD kidneys was discussed in last year’s report and
was activated in November 2002 (14). Data will be available
for the 2004 OPTN/SRTR Annual Report regarding results
from the first year of this attempt to improve the use of
organs from these donors.
Number of organs recovered per donor by year
Table 1: Mean number of organs recovered per deceased donor,
2000–02










Source: OPTN/SRTR data as of August 1, 2003.
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Note: 5362 deceased donors in 1994; 6081 in 2002. 
Source: 2003 OPTN/SRTR Annual Report, Table 2.1.
Figure 4: Percentage cause of death for organ donors, 1994 vs.
2002.
Transplant suitability of donated organs varied by the age of
the deceased and cause of death. Distribution of donor age
and cause of death are shown in Figures 3 and 4, respec-
tively. Due to these variations in suitability, the number of
organs recovered from each donor differed according to
the characteristics of the deceased. The mean number of
organs for all deceased donors from 2000 to 2002 was
3.6 organs per donor. Table 1 shows the mean number of
organs recovered by age group, from January 1, 2000 to
December 31, 2002.
The number of organs recovered is also directly influenced
by conditional consent, whereby families of the deceased
grant consent for donation but specify that certain organs
should not be removed. This behavior is prevalent and con-
tributes significantly to differences in the availability of or-
gans by organ types. Table 2 shows details on organs for
which consent was not obtained, with both prevalence of
and reasons shown by organ type. The proportion of re-
fusals because of emotional reasons is fairly constant; the
sole exception is for livers, which have a statistically sig-
nificantly higher proportion of refusals because of emo-
tional reasons than the overall average. The data suggest
that tailored educational efforts should be directed at the
public to address perceptions underlying this refusal be-
havior. It seems such educational effort would need to
be organ specific, because general messages conveying
the need for more organ donors apparently do not suffi-
ciently address beliefs underlying organ-specific denial of
consent.
Organ disposition among donors by year
and by organ
Background. Over the past decade, there has been a pro-
gressive increase in the number of deceased donors avail-
able for transplantation, from 4861 in 1993 to 6182 in 2002.
Unfortunately, this increase has been accompanied by an
even greater growth in demand, necessitating further im-
provement in our use of this resource. Below we seek to
identify the magnitude of the opportunity for increasing use
of donated organs.
There is currently a loss of potential organs at each step
between the time a family agrees to permit recovery of or-
gans from a deceased donor and the time the individual or-
gans are transplanted. This attrition between donation and
transplantation exerts an enormous impact on the candi-
date population. Unlike overall consent rates and donation
rates, which can only be modified by large-scale societal in-
terventions, an improvement in the rate of use of donated
organs might be achieved by changes in practice within
the transplant community. Some causes of nonutilization
are intrinsic to the health status of the donor, while oth-
ers relate to logistic failures at the recovery agency, the
transplant centers, or both. Finally, there is an ethical bal-
ance between the perceived need for the donated organ
and the willingness of the transplant team to extend the
medical and technical criteria for use of an organ from a
given donor. There are many more issues that affect the
utilization of available organs, which are, in many respects,
related to the willingness of transplant centers to consider
organs from expanded criteria donors (ECDs). The need to
more aggressively utilize available organs for the candidate
population as a whole competes with the expectation of
each individual candidate for an optimal organ. The use of
ECD organs requires structured analysis of the overall mor-
bidity faced by the population on the waiting list, as well
as an assessment of the impact of an organ with a par-
ticular risk factor for poor function or the transmission of
disease on the outcome of an individual transplant. Such
analyses have recently been performed by the SRTR per-
taining to the use of ECD organs in kidney transplantation
(14,15). Public focus on the decision to confer risk in graft
selection has necessitated greater attention on informed
consent for the individual recipient in the face of such risk
factors, like the potential transmission of an infectious dis-
ease from donor to recipient.
It is likely that some of the nonrecovery and nonuse of
donor organs may be attenuated by modifications of donor
American Journal of Transplantation 2004; 4 (Suppl. 9): 27–37 31
Akinlolu O. Ojo et al.
Table 2: Individual organs for which consent was not obtained (totals, percentage, and reasons cited), 1999–2001
Reasons consent not obtained, n (%)
% Without
consent∗ Family
Organ n (95% Cl) Religious Emotional Cultural conflict Other/unknown
Heart 700 4.1 7 (1) 502 (71.7) 14 (2) 59 (8.4) 118 (16.9)
(3.8–4.5)
Intestine 1971 11.7 6 (0.3) 1467 (74.4) 17 (0.9) 128 (6.5) 353 (17.9)
(11.1–12.3)
Kidney 106 0.6 1 (0.9) 75 (70.8) 0 (0) 7 (6.6) 23 (21.7)
(0.5–0.7)
Liver 225 1.3 1 (0.4) 180 (80.0) 4 (1.8) 9 (4) 31 (13.8)
(1.2–1.5)
Lung 1015 6 5 (0.5) 734 (72.3) 10 (1) 87 (8.6) 179 (17.6)
(5.6–6.4)
Pancreas 826 4.9 5 (0.6) 604 (73.1) 10 (1.2) 63 (7.6) 144 (17.4)
(4.6–5.2)
Source: SRTR analysis for the ACOT Heart and Lung Allocation Committee, May 30, 2002. Differences in rate are statistically significant.
Based on number of donors who had donated at least one organ with at least one other organ not donated because consent was not
obtained (n = 2435). ∗Based on total number of donors for the period (n = 16 903).
Table 3: Disposition of consented organs, 2002
Total number Percentage of Percentage of Percentage of Percentage of
of organs nonrecovered organs organs organs used
Organ consented1 organs2 transplanted3 discarded4 for research5
Heart 4436 49.9 49.2 0.2 0.1
Intestine 4070 97.2 2.6 <0.1 <0.1
Kidney 12 040 7.1 80.4 10.6 1.8
Liver 6018 10.8 82.5 3.1 3.4
Lung 9938 82.8 16.3 0.4 0.2
Pancreas 4771 60.8 30.4 7.0 1.5
Source: 2003 OPTN/SRTR Annual Report, Tables 3.1–3.18.
1Includes both recovered and nonrecovered organs for which consent was obtained.
2Donated organ not removed for medical reasons after consent was obtained.
3Donated organ was transplanted as intended.
4Donated organ was recovered but discarded because it was not transplantable or suitable for research.
5Donated organ was recovered, found to be not suitable for transplantation but used for research instead of being discarded.
management, selection practices by the transplant cen-
ters, or adjustments in the logistics of procurement and
allocation. Recognition of an opportunity to enhance the
efficiency of use of consented donors for all the organs
led to a consensus at an important conference in Crys-
tal City, Maryland, in 2002. Although many topics were
considered at this meeting, attention was focused on four
principal areas: tissue-matching based allocation of kid-
neys, medical management of heart and lung donors, the
splitting of livers, and donor selection issues related to
previous viral or neoplastic conditions of potential organ
donors (16).
2002 Disposition data. Disposition of organs, including non-
recovery of organs from consented donors, organ discard,
and use of recovered organs for research, varied by the
type of organ. Table 3 shows the rates of nonrecovery
and discard of recovered organs for 2002. As noted above,
almost half (46%) of the 41 273 organs consented for dona-
tion in 2002 were not recovered, with heart, intestine, and
lung accounting for 12%, 21%, and 44% of nonrecovered
organs, respectively. After poor organ function, infection
with hepatitis virus and/or HIV was the second most com-
mon recorded cause for nonrecovery. Less than 2% of all
donated organs were ultimately used for research. Discard
of recovered organs was highest for kidneys at 11%.
Nonutilization of organs from consented donors
To identify opportunities for increasing use of available
donors, we have displayed OPTN data to estimate the ‘use
efficiency’ of consented donors, which is the basis of this
analysis. If the denominator of total consented donors is
used as the baseline estimate of real potential, and the
actual number of organs transplanted the numerator, the
gap between the two represents ‘nonutilization’ of do-
nated organs. Loss occurs in two phases, nonrecovery of
organs from consented donors, and nonuse of recovered
organs. The standard reasons for nonrecovery, as reported
to the OPTN, are cardiac arrest, organ unsatisfactory, poor
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Table 4: Nonutilization by organ, 2002 and 1993
Potential organs Consent not Recovered
(deceased donors) recovered1 Percentage not used2 Percentage
Organ nonuse 2002
Heart 6182 2215 35.8 11 0.2
Lung 12 364 8231 66.6 38 0.3
Liver 6182 649 10.5 185 3.0
Kidney 12 364 858 6.9 1273 10.3
Pancreas 6182 2901 46.9 329 5.33
Intestine 6182 3960 64.1 4 0.1
Organ nonuse 1993
Heart 4861 1174 24.2 32 0.7
Lung 9722 5892 60.6 48 0.5
Liver 4861 802 16.5 193 4.0
Kidney 9722 385 4.0 566 5.8
Pancreas 4861 2261 46.5 76 1.6
Intestine 4861 21 0.4 4 0.1
Source: 2003 OPTN/SRTR Annual Report, Tables 3.2–3.6, 3.8, 3.9, 3.11, 3.12, 3.14, 3.15, 3.17, 3.18.
1Consent not recovered: represents organ donors from whom organs were not removed after consent was obtained because of medical
contraindication that was not evident prior to consent or lack of organ viability detected by testing or intraoperatively.
2Recovered not used: organs that were recovered and subsequently found to be unsuitable for transplantation.
organ function/infection, donor medical/social history,
biopsy findings, positive hepatitis/HIV/HTLV-1, no recipient
found, unknown, and other. The OPTN reporting categories
for reasons of nonuse are similar, but include extended is-
chemia time and positive hepatitis/CMV/HIV and do not
include cardiac arrest or positive hepatitis/HIV/HTLV-1.
Nonrecovery of consented organs accounts for the major-
ity of nonutilization, with ‘poor organ function/infection’ as
the leading category for all organs (ranging from 27% for in-
testines to 71% for lungs). It should be noted that the data
presented count two lungs for each donor, thus overes-
timating potential, because many lung transplants require
both lungs for a single recipient. Categories such as ‘poor
organ function’ are extremely subjective and are likely to
vary substantially between regions depending on practice
patterns among the transplant centers. In contrast to the
other organs, ‘no recipient found’ was the most common
reason for nonrecovery of intestines. This reflects the sta-
tus of intestine replacement as an emerging therapy for
intestine failure, rather than the standard of care.
Although nonrecovery of consented donors was by far the
largest contributor to nonutilization, nonuse of recovered
organs occurred frequently in some organ systems; 1275
kidneys and 333 pancreata were recovered but not used in
2002. This is likely to be due to the collective retrieval sys-
tems that are present in most OPOs, in which the organs
are recovered as a collective responsibility before the in-
tended recipients are determined. In contrast, hearts (11)
and lungs (39) were rarely declined at this phase in the
process, because the recipient surgery usually begins at
the time of retrieval from the donor. Livers were discarded
more often, usually due to biopsy data that became avail-
able after the recovery was completed.
The rates of nonrecovery and nonuse by organ are pre-
sented in Table 4. There are obvious differences between
the organs in terms of the ability to function following re-
trieval and implantation, which naturally leads to distinct
patterns of organ selection by the transplanting teams. For
example, heart, lung, and liver recipients need immediate
function of the grafts to sustain life. While livers can be
replaced emergently, this option rarely succeeds in heart
and lung transplantation.
Number and percentage of recovered organs
discarded by year and by organ
There is substantial variation in the utilization of organs
from consenting donors among transplant types. For exam-
ple, although there were 6182 consenting donors in 2002,
only 2221 (36%) resulted in a heart transplant while 5292
(86%) resulted in a liver transplant (Table 4). Over the past
decade, there has been a marked increase in the use of
livers and a more modest increase in the use of lungs, pan-
creata, and intestines, while there has been a proportional
decrease in the use of hearts and kidneys. The decrease
in the use of hearts and kidneys may be relative because
much of the increase in donation between 1993 and 2002
occurred in the older age groups, which are less likely to
be selected for heart and kidney donation. For example, in
the older age groups (50–64 and 65+), 859 more donors
were used in 2002 than in 1993.
In addition to variation in the use of donors by organ, there
is variation among OPOs reflecting different practice pat-
terns between transplant centers and the difficulties of
long-distance sharing. Unfortunately, such variations are
not discernible when working with aggregate data. This
is important because improvements in policy and prac-
tice need to deviate mean performance toward the results
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Table 5: Transplant rates of consented donors by organ, 2002 and 1993
Potential organs Local Shared Total Use
(deceased donors) transplants transplants transplants ratio
Organ use 2002
Heart 6182 1410 773 2183 35.3
Lung 12 364 944 675 1619 13.1
Liver 6182 3532 1431 4963 80.3
Kidney 12 364 6974 2707 9681 78.3
Pancreas 6182 1023 427 1450 23.5
Intestine 6182 27 78 105 1.7
Organ use 1993
Heart 4861 1653 696 2349 48.3
Lung 9722 565 430 995 10.2
Liver 4861 1894 1493 3387 69.7
Kidney 9722 6058 2233 8291 85.3
Pancreas 4861 594 178 772 15.9
Intestine 4861 15 19 34 0.7
Source: 2003 OPTN/SRTR Annual Report, Tables 3.1, 3.4, 3.7, 3.10, 3.13, 3.16.
achieved in the best practice if we are to better serve the
candidates on the waiting list. As an example, the use of
livers might be increased with a move to more aggressive
donor selection: overall, 4963 (80%) of consented donors
resulted in liver transplants in 2002, whereas in New York
state, livers were used from 88% of donors (17). If that
rate were replicated nationally, an additional 582 liver trans-
plants would result.
Allocation of organs leads to either local use or shared use,
under systems that vary by organ (Table 5). Organs may be
shared outside the local OPO either within the region or na-
tionally. Kidneys are shared under a system largely driven
by tissue typing, while other organs leave the region only
after they have been rejected for use by the local centers,
often based on an assessment of ‘donor quality’. It is unfor-
tunate that, under this system, organs of the lowest quality
need to travel the farthest, presumably incurring the great-
est ischemic time. The fact that so many organs are used
successfully despite being turned down locally suggests
that selection criteria remain highly subjective and far from
perfect. This effect is not inconsiderable, because 35% of
hearts and 27% of livers are used outside local OPOs (a
small number of OPOs have no local extrarenal transplant
centers, but these tend to serve small populations).
Failure to transplant organs recovered for that purpose (or-
gan discard) occurs at a much lower frequency compared
with nonrecovery, as noted above (Figure 5). The kidney
is the organ most likely to be discarded after recovery has
occurred. In 2002, 11% of recovered kidneys were dis-
carded. This represents an 87% increase in the discard
rate for recovered kidneys since 1993, when the discard
rate was 6%. Biopsy findings after recovery remains the
dominant cited reason, representing 42% of kidneys dis-
carded in 2002. The increase in discard rate from 1993 to
2002 was 191% for pancreas, but the discard rate fell by
32% for liver and 62% for heart. Reasons for the decline
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Source: 2003 OPTN/SRTR Annual Report, Tables 3.1, 3.4, 3.7, 3.10, 3.13, 3.16.
Figure 5: Cadaveric organ recovery outcomes, 2002.
ically evaluated. Unlike kidneys, once an extrarenal organ
is procured, the ability to successfully place it is very lim-
ited if the original procuring team elects not to go ahead
with the transplant. In addition, the risk of unreimbursed
procurement expenses may encourage nonrecovery when
extrarenal organ function is questionable, thereby paradox-
ically decreasing the rate of discard by increasing the rate
of nonrecovery.
Living Donors
Characteristics of living donors
As in 2001, the number of living organ donors (6618) ex-
ceeded the number of deceased donors (6182), but the dra-
matic increase in live donors seen during the past decade
may be slowing (Figure 6). This was especially apparent in
the significant declines in 2002 in living liver and living lung
donors (31% and 36% decrease, respectively), but also in
the modest 4% increase in living kidney donors compared
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Source:  2003 OPTN/SRTR Annual Report, Table 1.1
Figure 6: Deceased and living donors, 1993–2002.
with the 11% increase the previous year. This may reflect
a reappraisal of policies in the wake of a well-publicized
donor death (18).
Emancipated minors (donors under 18 years of age) are
rarely living organ donors. Between 1993 and 2002, there
were 35 emancipated minors who underwent living kid-
ney donation procedures. These donors accounted for less
than 0.1% of all living donors, and there does not appear
to be a trend (the average number of donors is four per
year). As stated earlier, the total number of living donors ex-
ceeded the number of deceased donors for the first time in
2001 (6560 vs. 6081). This trend continued in 2002, during
which there were 6618 living donors compared with 6182
deceased donors. It is notable that the number of living
donors changed minimally between 2001 and 2002 (6560
vs. 6618). This trend is in marked contrast with the pre-
ceding 5 years, during which the number of living donors
increased annually by 500–1000 donors. If the current trend
persists, it may signal a stabilization of the number of living
donors.
Racial composition of living donors has not changed sig-
nificantly. In 1993, whites, African-Americans, Asians, and
other races accounted for 83%, 14%, 2%, and 1% of liv-
ing donors, respectively, with the corresponding numbers
for 2002 being 83%, 13%, 3%, and 2%, respectively. De-
mographically, the age of living donors appears to be shift-
ing toward older donors (Figure 7). In 1993, 43% of living
donors were 18–34 years old, and this proportion declined
gradually to 33% in 2002. In contrast, the 50–64 years age
group accounted for 15% of living donors in 1993 and 18%
in 2002. There was no noticeable change in the distribution
of donors from the other age groups during this follow-up
period, although the absolute number of living donors aged
65 years and older increased from 28 in 1993 to 61 in 2002.
Living donor relation to recipient by year
and by organ
Interesting trends, with potentially important implications,
are noted in the relationship of living donors and their re-
43% 40% 38% 37% 35% 34% 34% 34% 33%
41% 43% 46% 46% 44% 45% 46% 47% 46% 45%
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Source: 2003 OPTN/SRTR Annual Report, Table 2.8
Figure 7: Living donor age, 1993–2002.
cipients. Table 6 shows trends in the distribution of living
donors according to the relationship with the recipients.
Half-siblings account for just 1% of living donors, but full
siblings, who previously comprised nearly one-half of all liv-
ing donors (45% in 1993), represented only 28% of living
donors in 2002. The fraction of offspring, spousal donors,
and nonspousal unrelated donors continued to increase
over the same time period.
Living donors by organ
Kidney donors continue to make up the overwhelming pro-
portion of living donors (94% in 2002). Lung lobe donors
declined from 56 in 1999 to 34, 39, and 25 in 2000, 2001,
and 2002, respectively. A marked decrease was observed
in the number of living liver segment donors in 2002 (Fig-
ure 8). The decline between 2001 and 2002 occurred in
all age groups and donor–recipient relationships of liver
donors and may be related to the negative publicity fol-
lowing the death of a living donor and the moratorium im-
posed on some living donor liver transplantation programs
(19–21).
Summary
The existing 59 OPOs function at the center of the de-
ceased donor organ donation process in the USA. The
OPOs continue to play a critical role in expanding the sci-
ence of donation and in the development of policies and
methods to enhance the realization of deceased donor
potential in the USA. Rates of nonrecovery and discard
of organs from deceased donors remains high. Although
there have been more living donors than deceased donors
in recent years, 2002 witnessed a much more modest
growth from this source. Absolute declines in living liver
and lung donation were also noted in 2002. Further re-
search is needed to identify all donors, improve consent
rates, and reduce rates of nonrecovery and discard.
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Table 6: Percentage distribution (number) of living donors according to relationship to recipients, 1993–2002
Relationship 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002
Parent 25.7% 22.0% 23.5% 22.1% 20.2% 18.8% 17.7% 14.1% 14.3% 12.9%
(747) (682) (820) (835) (818) (855) (881) (826) (938) (854)
Offspring 12.8% 11.5% 14.6% 14.1% 15.7% 14.9% 16.3% 18.2% 18.2% 18.4%
(372) (357) (509) (533) (636) (677) (811) (1066) (1194) (1218)
Full sibling 45.3% 41.9% 42.3% 38.7% 38.3% 35.7% 32.9% 31.7% 28.8% 27.7%
(1316) (1300) (1476) (1462) (1552) (1623) (1637) (1857) (1889) (1833)
Spouse 4.0% 4.2% 7.4% 9.2% 9.3% 11.7% 11.4% 11.3% 11.0% 10.8%
(116) (130) (258) (347) (377) (532) (567) (662) (722) (715)
Non-spouse 2.5% 2.6% 4.6% 5.9% 6.6% 7.7% 9.4% 14.1% 15.2% 17.6%
unrelated (73) (81) (160) (223) (267) (350) (468) (826) (997) (1165)





























Source:  2003 OPTN/SRTR Annual Report, Tables 2.10.
Figure 8: Living liver segment donors, 1998–2002.
Overall, depending on the organ type, opportunities to in-
crease the extraction of available organs seem to exist,
and may be of varying magnitude depending upon the or-
gan type. Most obvious is the ability to use damaged liv-
ers successfully because of the regenerative capacity of
that organ, leading to a high utilization rate. Approaches
to effect this change will require more aggressive analysis
and policies that create incentives for greater use of these
organs. Today, transplant centers are compared primarily
on their post-transplant survival rates, which do not create
incentives to serve the population at need by expanding
donor selection criteria aggressively. On a limited basis,
SRTR and Human and Health Services have analyzed the
probability of survival on the waiting list and other factors,
and they have attempted to document rates of refusal of
donor offers for different transplant centers. Current data
collection and reporting does not adequately demonstrate
the gap in utilization between best and worst practices,
and such data will be necessary in promoting change.
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